Cardinal Health Inc. (CAH)
NYSE
Closed
Oct 8, 2026
Day's Range
231.2552 wk Range
151.87Overview - CAH - Cardinal Health Inc.
Key Statistics
Valuation
Enterprise Value
58.39B
P/E (Trailing)
‪31.62‬
P/E (Forward)
‪16.23‬
PEG Ratio
‪0.46‬
Price / Sales (TTM)
‪0.20‬
Price / Book
‪-19.61‬
EV / EBITDA
‪13.76‬
Profitability
Gross Margin
‪4.02%‬
Profit Margin
‪0.67%‬
Operating Margin
‪1.33%‬
Return on Assets
‪3.72%‬
Return on Equity
‪-62.92%‬
Ownership
Shares Outstanding
233.00M
Float
232.03M
Short % of Shares Outstanding
‪3.32%‬
Held by Insiders
‪0.28%‬
Held by Institutions
‪91.48%‬
Price stats
Beta
‪0.51‬
50-Day Avg
‪232.62‬
200-Day Avg
‪217.89‬
Dividends
Payout Ratio
‪28.33%‬
Frequency
Quarterly
Analyst Consensus
17 analysts
Average price target
‪$ 270.94‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CAH - Cardinal Health Inc.
Peers - CAH - Cardinal Health Inc.
Peer Comparison
Compared with companies in Medical Distribution listed on NYSE.
Profile Summary - CAH - Cardinal Health Inc.
About
Cardinal Health Inc. is a healthcare services and products company that supports hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients at home. It distributes branded, generic, specialty, and over-the-counter pharmaceuticals, while also providing pharmacy management,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
